New drug SHR-A1811 tested in 1,000 lung cancer patients in Real-World setting
Disease control
Not yet recruiting
This study looks at how safe and effective the drug SHR-A1811 is for Chinese patients with advanced or spreading non-small cell lung cancer that has a specific genetic change called HER2 alteration. About 1,000 adults will be followed as they receive the drug as part of their nor…
Sponsor: Nanjing Tianyinshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC